CADL
Candel Therapeutics Inc
11.00$
-4.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 90.1% | 88.2% | 86.9% | 85.8% | 84.0% | 97.1% | 97.1% | 97.8% | 96.3% | 95.6% | 97.9% | 98.1% | |
| 85.9% | 84.9% | 82.4% | 81.0% | 77.0% | 96.1% | 96.1% | 95.0% | 92.9% | 95.6% | 96.5% | 96.8% | |
| 85.9% | 84.9% | 82.4% | 81.0% | 77.0% | 96.1% | 96.1% | 95.0% | 92.9% | 95.6% | 96.5% | 96.8% | |
| 54.0% | 69.4% | 80.8% | 137.7% | 170.9% | 37.9% | 22.1% | 14.9% | 14.4% | 58.5% | 31.6% | 39.4% | |
| 20.6% | 34.0% | 43.4% | 52.8% | 71.0% | 35.1% | 20.9% | 13.9% | 11.7% | 7.2% | 3.5% | 6.1% | |
| 13.2% | 22.6% | 33.0% | 41.1% | 50.9% | 9.8% | 10.2% | 6.9% | 5.0% | 0.4% | 0.2% | 0.2% | |
| 0.5% | 1.0% | 1.5% | 1.6% | 1.4% | 0.2% | 0.8% | 1.8% | 1.2% | 0.9% | 1.5% | 2.5% | |
| 30.1% | 29.7% | 31.9% | 28.4% | 23.5% | 2.4% | 0.9% | 0.9% | 1.0% | 37.6% | 23.5% | 23.0% | |
| 46.0% | 30.6% | 19.2% | -37.7% | -70.9% | 62.1% | 77.9% | 85.1% | 85.6% | 41.5% | 68.4% | 60.6% | |
| -251.6% | -328.6% | -465.3% | -632.4% | -827.9% | -179.9% | -192.7% | -178.9% | -214.6% | -184.0% | -118.5% | -133.6% | |
| 57.8% | 69.5% | 93.5% | 112.8% | 148.8% | 33.3% | 33.0% | 48.6% | 58.6% | 43.9% | 30.9% | 35.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.